- Home
- LOBO vs PYPD Comparison
LOBO vs PYPD Comparison
Compare LOBO & PYPD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LOBO
- PYPD
- Stock Information
- Founded
- LOBO 2014
- PYPD 2008
- Country
- LOBO China
- PYPD Israel
- Employees
- LOBO N/A
- PYPD N/A
- Industry
- LOBO
- PYPD Medical/Dental Instruments
- Sector
- LOBO
- PYPD Health Care
- Exchange
- LOBO NYSE
- PYPD Nasdaq
- Market Cap
- LOBO 16.3M
- PYPD 19.4M
- IPO Year
- LOBO 2024
- PYPD 2020
- Fundamental
- Price
- LOBO $1.79
- PYPD $3.30
- Analyst Decision
- LOBO
- PYPD Strong Buy
- Analyst Count
- LOBO 0
- PYPD 2
- Target Price
- LOBO N/A
- PYPD $10.50
- AVG Volume (30 Days)
- LOBO 14.9K
- PYPD 49.0K
- Earning Date
- LOBO 09-30-2024
- PYPD 02-12-2025
- Dividend Yield
- LOBO N/A
- PYPD N/A
- EPS Growth
- LOBO N/A
- PYPD N/A
- EPS
- LOBO 0.00
- PYPD N/A
- Revenue
- LOBO $19,469,766.00
- PYPD N/A
- Revenue This Year
- LOBO $72.16
- PYPD N/A
- Revenue Next Year
- LOBO $41.04
- PYPD N/A
- P/E Ratio
- LOBO $1,496.48
- PYPD N/A
- Revenue Growth
- LOBO N/A
- PYPD N/A
- 52 Week Low
- LOBO $1.35
- PYPD $2.37
- 52 Week High
- LOBO $4.70
- PYPD $7.00
- Technical
- Relative Strength Index (RSI)
- LOBO N/A
- PYPD 55.20
- Support Level
- LOBO N/A
- PYPD $2.93
- Resistance Level
- LOBO N/A
- PYPD $3.35
- Average True Range (ATR)
- LOBO 0.00
- PYPD 0.24
- MACD
- LOBO 0.00
- PYPD 0.04
- Stochastic Oscillator
- LOBO 0.00
- PYPD 93.15
About LOBO LOBO EV TECHNOLOGIES LTD
Lobo EV Technologies Ltd is an electric vehicle manufacturer and seller company. It designs, develops, manufactures, and sells e-bicycles, e-mopeds, e-tricycles, and electric off-highway four-wheeled shuttles such as golf carts and mobility scooters for the elderly and disabled persons, also provides automobile information and entertainment software development and design services to customers. The company operates in two operating segments: Electric vehicles and accessories sales which generates key revenue, and software royalties and development and design services. It generates all of its revenue within the People's Republic of China.
About PYPD PolyPid Ltd.
PolyPid Ltd is a clinical-stage biopharmaceutical company engaged in the research and development of products based on PLEX (Polymer-Lipid Encapsulation MatriX), the company's proprietary drug delivery technology. PLEX is capable of encapsulating many types of drugs to enable targeted, localized drug delivery into the body over extended periods of time with pre-determined release rates thus optimizing drug treatment regimens. BonyPid, PolyPid, Opzifend, Ssisurg, Elyfssi, Baczenssi, Opzifend and Bacyssio are trademarks of the company. Its product candidate include D-PLEX100 for prevention of SSI in soft tissue and OncoPLEX which can be a potential Intra-tumoral therapy.